Get started
Work

STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant

Year: 2022
Type: article
DOI: 10.1016/j.jconrel.2022.05.017
Authors: Matthew D. Gallovic, Robert D. Junkins, Adam M. Sandor, Erik S. Pena, Christopher J. Sample, Ariel K. Mason, Leslee C. Arwood, Rebecca A. Sahm, Eric M. Bachelder, Kristy M. Ainslie, Gregory D. Sempowski, Jenny P.-Y. Ting
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: bronze
Funders: National Science Foundation, North Carolina Biotechnology Center, National Institutes of Health, Centers for Disease Control and Prevention, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Division of Electrical, Communications and Cyber Systems
Awards: G1085565077, G120653876, CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP), G1628498378, G1741978266, G3460830468, G3688390984, NNCI: North Carolina Research Triangle Nanotechnology Network (RTNN), Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants, G5039591432, G542087556, G6370326072, G8379456544, G8392389417, G8657803787, G9000008545, G9000048827, G9000068366, G9000328894, Cancer Center Support Grant
OpenAlex ID: W4280631023
FWCI: 3.662
Cites: 70
Cited by: 28
Related to: 10